Neural mechanisms and management of obesity-related hypertension

被引:28
|
作者
Esler M.D. [1 ]
Eikelis N. [1 ]
Lambert E. [1 ]
Straznicky N. [1 ]
机构
[1] Baker IDI Heart and Diabetes Institute, Melbourne, VIC 8008, St. Kilda Road Central
关键词
Obstructive Sleep Apnea; Essential Hypertension; Sympathetic Nerve; Sympathetic Nervous Activity; Human Obesity;
D O I
10.1007/s11886-008-0072-7
中图分类号
学科分类号
摘要
The sympathetic nervous system is activated in human obesity and in the analogous experimental obesity produced by overfeeding. The causes remain uncertain and may be multiple. The consequences include hypertension, probably attributable to activation of the sympathetic outflow to the kidneys, and, more disputed, insulin resistance. The pattern of sympathetic activation in normal-weight and obesity-related hypertension differs in terms of the firing characteristics of individual sympathetic fibers (increased rate of nerve firing in normal-weight hypertensives, increased number of active fibers firing at a normal rate in obesity-hypertension) and the sympathetic outflows involved. The underlying mechanisms and the adverse consequences of the two modes of sympathetic activation may differ. Should antihypertensive drug therapy in obesity-hypertension specifically target the existing neural pathophysiology? Such an approach can be advocated on theoretical grounds. Perhaps more important is the requirement that chosen antihypertensives do not cause weight gain or insulin resistance. © Current Medicine Group LLC 2008.
引用
收藏
页码:456 / 463
页数:7
相关论文
共 50 条
  • [31] IS THERE A TRANSIENT, OBESITY-RELATED HYPERTENSION OF ADOLESCENCE
    STICKLER, GB
    CLINICAL PEDIATRICS, 1986, 25 (11) : 573 - 574
  • [32] Factors Responsible for Obesity-Related Hypertension
    Lim, Kyungjoon
    Jackson, Kristy L.
    Sata, Yusuke
    Head, Geoffrey A.
    CURRENT HYPERTENSION REPORTS, 2017, 19 (07)
  • [33] Role of leptin in obesity-related hypertension
    Aizawa-Abe, M
    Ogawa, Y
    Masuzaki, H
    Ebihara, K
    Shintani, M
    Miyanaga, F
    Nakao, K
    JOURNAL OF HYPERTENSION, 2000, 18 : S120 - S120
  • [34] Adipocytes, aldosterone and obesity-related hypertension
    Cat, Aurelie Nguyen Dinh
    Friederich-Persson, Malou
    White, Anna
    Touyz, Rhian M.
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2016, 57 (01) : F7 - F21
  • [35] The Role of Aldosterone in Obesity-Related Hypertension
    Kawarazaki, Wakako
    Fujita, Toshiro
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (04) : 415 - 423
  • [36] Role of leptin in obesity-related hypertension
    Haynes, WG
    EXPERIMENTAL PHYSIOLOGY, 2005, 90 (05) : 683 - 688
  • [37] Treatment strategies for obesity-related hypertension
    Efrain Reisin
    Current Hypertension Reports, 2008, 10 : 129 - 130
  • [38] Obesity-related hypertension and chronic kidney disease: from evaluation to management
    Jung, Mi-Hyang
    Ihm, Sang-Hyun
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2023, 42 (04) : 431 - 444
  • [39] Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery
    Shariq, Omair A.
    McKenzie, Travis J.
    GLAND SURGERY, 2020, 9 (01) : 80 - 93
  • [40] Mechanisms underlying obesity-related hypertension: an experimental weight gain study in humans
    Middlemiss, Jessica
    Maki-Petaja, Kaisa
    McEniery, Carmel
    JOURNAL OF HUMAN HYPERTENSION, 2019, 33 : 6 - 6